Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Peter Naredi

Professor/ chief physician

Peter Naredi
Professor/ chief physician , Head of Department
peter.naredi@gu.se
+46 31 786 4065
0706-814981

Postal Address: Sahlgrenska sjukhuset, 41345 Göteborg
Visiting Address: Blå stråket 5, vån 5, SU/Sahlgrenska , 41345 Göteborg


Institute of Clinical Sciences (More Information)
Box 426
405 30 Göteborg
www.clinsci.gu.se
klinvet@gu.se

Visiting Address: Medicinaregatan 3, plan 5 , 405 30 Göteborg

About Peter Naredi

Vice chairman at The Institute of Clinical Sciences and Professor of Surgery, Chairman of the Department of Surgery Sahlgrenska Academy, University of Gothenburg

Clinicaly I work as a cancer surgeon with special focus on the upper gastrointestinal tract and the liver.

Below are some of the projects I'm involved in right now. I am also included in an international network for the treatment of colorectal liver metastases.

1 Multidisciplinary treatment with surgery and chemotherapy of liver metastases from colorectal cancer

Cancer of the colon and rectum is common and almost half of the patients have or will have metastases (metastases) in the liver. When the spread is limited to the liver removal of liver metastases can be curative. Therefore it is important to detect liver metastases and evaluate the role of controls after the operation of the primary cancer.

The purpuse of our resarch is to find more patients that can be treated with a curative intention for liver metastases from colorectal cancer. We also want to improve chemotherapy by counteracting the resistance which tumors have or develop during treatment. We analyze the diagnostics of liver metastases, treatment decisions and outcomes of treatments. In the worm C. elegans, we are studying how to best combine targeted drugs and chemotherapy. In C.elegans, we investigate how to inhibit the function of the protein ASNA1 and thus make cancer cells more sensitive to chemotherapy. Read more on the Cancer Society's website.

2 The impact of host dependent factors and tumour interaction on survival for patients with Hepatocellular carcinoma
Patients diagnosed with hepatocellular carcinoma (HCC) often have a poor prognosis and the five-year survival rates are among the worst among tumor types, about 10 per cent. If the patients tumour is not to advanced, liver transplantation is a treatment option.
Today the development of the HCC is ruled by underlying factors, which makes it important to investigate individual specific characteristics in relation to the treatment effects. Currently used selection criteria may exclude some patients who would have survived with a liver transplantation. By exploring new and hopefully more refined and specific diagnostic instruments, we hope to expand the criteria for liver transplantation and also to identify those patients for whom palliative treatment is the best option.

3a Combat malignant melanoma on two fronts
More and more people are affected by cancer. In this project we will investigate how the disease arises and search for new drug targets - processes or mechanisms that may be affected by medication. We will study the disease in transgenic mice, and in mice bearing human tumours. The treatment will become more individualized and patients can receive proper treatment while unnecessary medication is avoided. The goal is new life-saving drugs.  Read more at the webbsait of Knut och Alice Wallenbergsstiftelsen

3b When metastases of malignant melanoma are localized to a limb or in the liver they can be treated with isolated hyperthermic perfusion of the cytotoxic drug melphalan. In a perfusion system high doses of chemotherapy drugs are given locally with less harm to the patient. How the effects of this treatment affects the body's own immune mechanisms are poorly studied. One hypothesis that we study is that it induces immunogenic cell death and activation of the immune system.

Team members within the research groups
• Gautam Kao
• Rahul Gauer
• Eva Philipsson
• Peter Scherman
• Dorota Raj
• Magnus Rizell
• Malin Sternby Eilard.
• Jonas Nilsson
• Anna Martner
• Per Lindner
• Roger Olofsson

Financiers of the projects
• Cancerfonden
• BioCare
• ALF-projektmedel Västra Götaland
• Knut och Alice Wallenbergs stiftelsen (Martin Bergö huvudsökande)
• Sahlgrenska akademin

Ongoing PhD
Main supervisor
• Malin Sternby Eilard
• Junko Johannsson

Interview in the media
Intervju Cancer World - Peter Naredi: a “can do” leader for Europe's cancer surgeons
Intervju MedScape inför 2015 års ECC-konferens med tema - “Att förstärka de multidiciplinära teamen inom cancervården
Intervju Akademiliv 2013 -En cancerkirurg med framtidstro
eCancer - Prof Naredi talks to ecancertv at ECC 2015 about the use of surgery in synchronous oligometastatic disease.

More
• President-elect i ECCO (European cancer organisation)
Scientific Chair of the congress ECC2015, Vienna.
• Congress chair ECCO congress Amsterdam 2017
Past president at The European Society of Surgical Oncology ESSO 2011
• 2015 Invited by the Public Health Ministry in Thailand and Vietnamn, as speaker at a seminar in Bangkok, theme -Thailand and Sweden can share best practices on healthcare solutions for an ageing society.

Honorary Member
• European Society for Therapeutic Radiology and Oncology (ESTRO). 2012
• Society of Italian Surgical Oncology (SICO). 2012
Svensk kirurgisk förening. 2012
Hellenic society of Surgical Oncology. 2013
BASO – the organisation for Cancer Surgery, UK. 2015
 

Latest publications

Multidisciplinary training of cancer specialists in Europe
K. Benstead, N. S. Turhal, N. O'Higgins, L. Wyld, M. Czarnecka-Operacz et al.
European Journal of Cancer, Journal article 2017
Journal article

ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review
G. Beets, D. Sebag-Montefiore, E. Andritsch, D. Arnold, M. Beishon et al.
Critical Reviews in Oncology Hematology, Journal article 2017
Journal article

ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review
E. Andritsch, M. Beishon, S. Bielack, S. Bonvalot, P. Casali et al.
Critical Reviews in Oncology Hematology, Journal article 2017
Journal article

The European Cancer Patient's Bill of Rights, update and implementation 2016
M. Lawler, I. Banks, K. Law, T. Albreht, J. P. Armand et al.
Esmo Open, Journal article 2016
Journal article

Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.
Marcela Ewing, Peter Naredi, Chenyang Zhang, Jörgen Månsson
The British journal of general practice : the journal of the Royal College of General Practitioners, Journal article 2016
Journal article

Present and future role of surgery in metastatic gastrointestinal malignancies
Peter Naredi, Roger Olofsson Bagge
Current Opinion in Oncology, Journal article 2016
Journal article

Asna1/TRC40 controls beta cell function and ER homeostasis by ensuring retrograde transport.
Stefan Norlin, Vishal S Parekh, Peter Naredi, Helena Edlund
Diabetes, Journal article 2016
Journal article

Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Hanna Nyström, Björn Tavelin, Moa Björklund, Peter Naredi, Malin Sund
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, Journal article 2015
Journal article

Showing 1 - 10 of 140

2017

Multidisciplinary training of cancer specialists in Europe
K. Benstead, N. S. Turhal, N. O'Higgins, L. Wyld, M. Czarnecka-Operacz et al.
European Journal of Cancer, Journal article 2017
Journal article

ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review
G. Beets, D. Sebag-Montefiore, E. Andritsch, D. Arnold, M. Beishon et al.
Critical Reviews in Oncology Hematology, Journal article 2017
Journal article

ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review
E. Andritsch, M. Beishon, S. Bielack, S. Bonvalot, P. Casali et al.
Critical Reviews in Oncology Hematology, Journal article 2017
Journal article

2016

The European Cancer Patient's Bill of Rights, update and implementation 2016
M. Lawler, I. Banks, K. Law, T. Albreht, J. P. Armand et al.
Esmo Open, Journal article 2016
Journal article

Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.
Marcela Ewing, Peter Naredi, Chenyang Zhang, Jörgen Månsson
The British journal of general practice : the journal of the Royal College of General Practitioners, Journal article 2016
Journal article

Present and future role of surgery in metastatic gastrointestinal malignancies
Peter Naredi, Roger Olofsson Bagge
Current Opinion in Oncology, Journal article 2016
Journal article

Asna1/TRC40 controls beta cell function and ER homeostasis by ensuring retrograde transport.
Stefan Norlin, Vishal S Parekh, Peter Naredi, Helena Edlund
Diabetes, Journal article 2016
Journal article

2015

Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Hanna Nyström, Björn Tavelin, Moa Björklund, Peter Naredi, Malin Sund
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, Journal article 2015
Journal article

Showing 1 - 10 of 140

Page Manager: Katarina Olinder Eriksson|Last update: 7/18/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?